Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely afatinib dimaleate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely afatinib dimaleate 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely afatinib dimaleate 40 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely afatinib dimaleate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely afatinib dimaleate 20 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely afatinib dimaleate 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely afatinib dimaleate 30 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely afatinib dimaleate 40 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely afatinib dimaleate 40 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely afatinib dimaleate 20 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely afatinib dimaleate 30 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely afatinib dimaleate 40 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely afatinib (as afatinib dimaleate) 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely afatinib (as afatinib dimaleate) 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Afatinib (as afatinib dimaleate) 30 mg oral tablet |
Has precise active ingredient |
True |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely afatinib (as afatinib dimaleate) 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Afatinib dimaleate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |